Role of biomarkers in early infectious complications after lung transplantation.

Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that incl...

Full description

Bibliographic Details
Main Authors: Borja Suberviola, Luzdivina Rellan, Jordi Riera, Reyes Iranzo, Ascension Garcia Campos, Juan Carlos Robles, Rosario Vicente, Eduardo Miñambres, Miguel Santibanez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5509107?pdf=render
id doaj-fe647cd0c26b4871ae5bd574ba9f2655
record_format Article
spelling doaj-fe647cd0c26b4871ae5bd574ba9f26552020-11-25T01:20:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018020210.1371/journal.pone.0180202Role of biomarkers in early infectious complications after lung transplantation.Borja SuberviolaLuzdivina RellanJordi RieraReyes IranzoAscension Garcia CamposJuan Carlos RoblesRosario VicenteEduardo MiñambresMiguel SantibanezInfections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days.We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively).In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.http://europepmc.org/articles/PMC5509107?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Borja Suberviola
Luzdivina Rellan
Jordi Riera
Reyes Iranzo
Ascension Garcia Campos
Juan Carlos Robles
Rosario Vicente
Eduardo Miñambres
Miguel Santibanez
spellingShingle Borja Suberviola
Luzdivina Rellan
Jordi Riera
Reyes Iranzo
Ascension Garcia Campos
Juan Carlos Robles
Rosario Vicente
Eduardo Miñambres
Miguel Santibanez
Role of biomarkers in early infectious complications after lung transplantation.
PLoS ONE
author_facet Borja Suberviola
Luzdivina Rellan
Jordi Riera
Reyes Iranzo
Ascension Garcia Campos
Juan Carlos Robles
Rosario Vicente
Eduardo Miñambres
Miguel Santibanez
author_sort Borja Suberviola
title Role of biomarkers in early infectious complications after lung transplantation.
title_short Role of biomarkers in early infectious complications after lung transplantation.
title_full Role of biomarkers in early infectious complications after lung transplantation.
title_fullStr Role of biomarkers in early infectious complications after lung transplantation.
title_full_unstemmed Role of biomarkers in early infectious complications after lung transplantation.
title_sort role of biomarkers in early infectious complications after lung transplantation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days.We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively).In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.
url http://europepmc.org/articles/PMC5509107?pdf=render
work_keys_str_mv AT borjasuberviola roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT luzdivinarellan roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT jordiriera roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT reyesiranzo roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT ascensiongarciacampos roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT juancarlosrobles roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT rosariovicente roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT eduardominambres roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
AT miguelsantibanez roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation
_version_ 1725135200459948032